293 related articles for article (PubMed ID: 34062073)
1. Pathophysiological Characteristics Linking Type 2 Diabetes Mellitus and Colorectal Neoplasia.
Grega T; Vojtechova G; Gregova M; Zavoral M; Suchanek S
Physiol Res; 2021 Aug; 70(4):509-522. PubMed ID: 34062073
[TBL] [Abstract][Full Text] [Related]
2. Diabetes and Colorectal Cancer Risk: A New Look at Molecular Mechanisms and Potential Role of Novel Antidiabetic Agents.
Vekic J; Zeljkovic A; Stefanovic A; Giglio RV; Ciaccio M; Rizzo M
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830295
[TBL] [Abstract][Full Text] [Related]
3. Is diabetes a causal agent for colorectal cancer? Pathophysiological and molecular mechanisms.
Giouleme O; Diamantidis MD; Katsaros MG
World J Gastroenterol; 2011 Jan; 17(4):444-8. PubMed ID: 21274373
[TBL] [Abstract][Full Text] [Related]
4. Type 2 Diabetes Mellitus Associated with Obesity (Diabesity). The Central Role of Gut Microbiota and Its Translational Applications.
Ortega MA; Fraile-Martínez O; Naya I; García-Honduvilla N; Álvarez-Mon M; Buján J; Asúnsolo Á; de la Torre B
Nutrients; 2020 Sep; 12(9):. PubMed ID: 32917030
[TBL] [Abstract][Full Text] [Related]
5. Socioeconomic Status: The Missing Link Between Obesity and Diabetes Mellitus?
Volaco A; Cavalcanti AM; Filho RP; Précoma DB
Curr Diabetes Rev; 2018; 14(4):321-326. PubMed ID: 28637406
[TBL] [Abstract][Full Text] [Related]
6. Obesity and colorectal cancer.
Aleksandrova K; Nimptsch K; Pischon T
Front Biosci (Elite Ed); 2013 Jan; 5(1):61-77. PubMed ID: 23276970
[TBL] [Abstract][Full Text] [Related]
7. Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients.
Sciacca L; Vigneri R; Tumminia A; Frasca F; Squatrito S; Frittitta L; Vigneri P
Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):808-15. PubMed ID: 23932729
[TBL] [Abstract][Full Text] [Related]
8. From role of gut microbiota to microbial-based therapies in type 2-diabetes.
Ebrahimzadeh Leylabadlo H; Sanaie S; Sadeghpour Heravi F; Ahmadian Z; Ghotaslou R
Infect Genet Evol; 2020 Jul; 81():104268. PubMed ID: 32126303
[TBL] [Abstract][Full Text] [Related]
9. Role of Gut Microbiota on Onset and Progression of Microvascular Complications of Type 2 Diabetes (T2DM).
Tanase DM; Gosav EM; Neculae E; Costea CF; Ciocoiu M; Hurjui LL; Tarniceriu CC; Maranduca MA; Lacatusu CM; Floria M; Serban IL
Nutrients; 2020 Dec; 12(12):. PubMed ID: 33276482
[TBL] [Abstract][Full Text] [Related]
10. The Effects of Type 2 Diabetes Mellitus on Organ Metabolism and the Immune System.
Daryabor G; Atashzar MR; Kabelitz D; Meri S; Kalantar K
Front Immunol; 2020; 11():1582. PubMed ID: 32793223
[TBL] [Abstract][Full Text] [Related]
11. Gut Microbiota-Mediated Inflammation and Gut Permeability in Patients with Obesity and Colorectal Cancer.
Sánchez-Alcoholado L; Ordóñez R; Otero A; Plaza-Andrade I; Laborda-Illanes A; Medina JA; Ramos-Molina B; Gómez-Millán J; Queipo-Ortuño MI
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32947866
[TBL] [Abstract][Full Text] [Related]
12. Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease.
Sabatino A; Regolisti G; Cosola C; Gesualdo L; Fiaccadori E
Curr Diab Rep; 2017 Mar; 17(3):16. PubMed ID: 28271466
[TBL] [Abstract][Full Text] [Related]
13. Interindividual variability in gut microbiota and host response to dietary interventions.
Healey GR; Murphy R; Brough L; Butts CA; Coad J
Nutr Rev; 2017 Dec; 75(12):1059-1080. PubMed ID: 29190368
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms linking diet and colorectal cancer: the possible role of insulin resistance.
Bruce WR; Wolever TM; Giacca A
Nutr Cancer; 2000; 37(1):19-26. PubMed ID: 10965515
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota as the critical correlation of polycystic ovary syndrome and type 2 diabetes mellitus.
Duan L; An X; Zhang Y; Jin D; Zhao S; Zhou R; Duan Y; Zhang Y; Liu X; Lian F
Biomed Pharmacother; 2021 Oct; 142():112094. PubMed ID: 34449321
[TBL] [Abstract][Full Text] [Related]
16. Role of the Gastrointestinal Tract Microbiome in the Pathophysiology of Diabetes Mellitus.
Sohail MU; Althani A; Anwar H; Rizzi R; Marei HE
J Diabetes Res; 2017; 2017():9631435. PubMed ID: 29082264
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse?
Shanik MH; Xu Y; Skrha J; Dankner R; Zick Y; Roth J
Diabetes Care; 2008 Feb; 31 Suppl 2():S262-8. PubMed ID: 18227495
[TBL] [Abstract][Full Text] [Related]
18. Diabetes and Colorectal Cancer Risk: Clinical and Therapeutic Implications.
Yu GH; Li SF; Wei R; Jiang Z
J Diabetes Res; 2022; 2022():1747326. PubMed ID: 35296101
[TBL] [Abstract][Full Text] [Related]
19. From Obesity to Diabetes: The Role of the Adipose Organ.
Colleluori G; Perugini J; Giordano A; Cinti S
Handb Exp Pharmacol; 2022; 274():75-92. PubMed ID: 35044536
[TBL] [Abstract][Full Text] [Related]
20. Diabetes mellitus type 2 - an independent risk factor for cancer?
Grote VA; Becker S; Kaaks R
Exp Clin Endocrinol Diabetes; 2010 Jan; 118(1):4-8. PubMed ID: 20127570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
